Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gennett M. Pike"'
Autor:
Marshall D. Behrens, Robert J. Stiles, Gennett M. Pike, Laura A. Sikkink, Yongxian Zhuang, Jia Yu, Liewei Wang, Judy C. Boughey, Matthew P. Goetz, Mark J. Federspiel
Publikováno v:
Molecular Therapy: Oncolytics, Vol 27, Iss , Pp 239-255 (2022)
Historically, the clinical utility of oncolytic virotherapy as a treatment for a wide range of cancer types was first demonstrated by three pilot human clinical trials conducted in Japan in the 1970s and 1980s using a wild-type Urabe mumps virus (MuV
Externí odkaz:
https://doaj.org/article/b9ed91b0cb974385bc37be3b4a346fb0
Publikováno v:
Journal of Virology. 89:2136-2148
The study of the interactions of subgroup A avian sarcoma and leucosis viruses [ASLV(A)] with the TVA receptor required to infect cells offers a powerful experimental model of retroviral entry. Several regions and specific residues in the TVA recepto
Autor:
Benjamin J. Madden, Deborah C. Melder, Mark J. Federspiel, M. Cristine Charlesworth, Gennett M. Pike
Publikováno v:
Journal of Biological Chemistry. 286:17954-17967
Enveloped viruses must fuse the viral and cellular membranes to enter the cell. Understanding how viral fusion proteins mediate entry will provide valuable information for antiviral intervention to combat associated disease. The avian sarcoma and leu
Autor:
Gennett M. Pike, Mark J. Federspiel, Scott H. Kaufmann, Changming Yu, Cristina Correia, Tommy A. Rinkoski
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 112(32)
Antibody-based therapeutics have now had success in the clinic. The affinity and specificity of the antibody for the target ligand determines the specificity of therapeutic delivery and off-target side effects. The discovery and optimization of high-
Autor:
Gennett M, Pike, Benjamin J, Madden, Deborah C, Melder, M Cristine, Charlesworth, Mark J, Federspiel
Publikováno v:
The Journal of biological chemistry. 286(20)
Enveloped viruses must fuse the viral and cellular membranes to enter the cell. Understanding how viral fusion proteins mediate entry will provide valuable information for antiviral intervention to combat associated disease. The avian sarcoma and leu